Innoviva (INVA) Dividends Paid - Common (2014 - 2022)
Innoviva posted quarterly Dividends Paid - Common of $69.8 million for Q3 2022, up 50.59% year-on-year from $46.4 million in Q3 2021, and up 631.23% on a QoQ basis from $9.5 million in Q2 2022.
Innoviva (INVA) has 9 years of Dividends Paid - Common data on file, last reported at $69.8 million in Q3 2022.
- For the quarter ending Q3 2022, Dividends Paid - Common rose 50.59% year-over-year to $69.8 million; the trailing twelve-month figure through Sep 2023 stood at $69.8 million (down 47.2% YoY), and the FY2022 full-year result was $69.8 million, up 17.41% from the prior year.
- Dividends Paid - Common for Q3 2022 stood at $69.8 million, up from $9.5 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $69.8 million in Q3 2022 and bottomed at $3000.0 in Q2 2019.
- The 5-year median for Dividends Paid - Common is $8.0 million (2022), against an average of $13.8 million.
- The widest annual swing landed in 2019, when Dividends Paid - Common sank 99.65%; it then soared 404966.67% in 2020.
- A 5-year view of Dividends Paid - Common shows it stood at $3.1 million in 2018, then jumped by 243.72% to $10.5 million in 2019, then slumped by 76.17% to $2.5 million in 2020, then surged by 1745.46% to $46.4 million in 2021, then jumped by 50.59% to $69.8 million in 2022.
- The last three Dividends Paid - Common figures came in at $69.8 million (Q3 2022), $9.5 million (Q2 2022), and $6.5 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 97.80 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 69.81 Mn |
| Sep 30, 2022 | 69.81 Mn |
| Jun 30, 2022 | 9.55 Mn |
| Jun 30, 2022 | 9.55 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Sep 30, 2021 | 46.36 Mn |
| Sep 30, 2021 | 46.36 Mn |
| Jun 30, 2021 | 20.16 Mn |
| Jun 30, 2021 | 20.16 Mn |
| Mar 31, 2021 | 21.29 Mn |
| Mar 31, 2021 | 21.29 Mn |
| Dec 31, 2020 | 2.51 Mn |
| Dec 31, 2020 | 2.51 Mn |
| Jun 30, 2020 | 12.15 Mn |
| Jun 30, 2020 | 12.15 Mn |
| Mar 31, 2020 | 15.81 Mn |
| Mar 31, 2020 | 15.81 Mn |
| Dec 31, 2019 | 10.54 Mn |
| Dec 31, 2019 | 10.54 Mn |
| Jun 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 8,000.00 |
| Mar 31, 2019 | 8,000.00 |
| Dec 31, 2018 | 3.07 Mn |
| Dec 31, 2018 | 3.07 Mn |
| Sep 30, 2018 | 1.99 Mn |
| Sep 30, 2018 | 1.99 Mn |
| Jun 30, 2018 | 861,000.00 |
| Jun 30, 2018 | 861,000.00 |
| Mar 31, 2018 | 38,000.00 |
| Mar 31, 2018 | 38,000.00 |
| Dec 31, 2017 | 281,000.00 |
| Dec 31, 2017 | 281,000.00 |
| Sep 30, 2017 | -107,000.00 |
| Sep 30, 2017 | -107,000.00 |
| Jun 30, 2017 | 40,000.00 |
| Jun 30, 2017 | 40,000.00 |
| Mar 31, 2017 | 67,000.00 |
| Mar 31, 2017 | 67,000.00 |
| Dec 31, 2016 | 65,000.00 |
| Dec 31, 2016 | 65,000.00 |
| Sep 30, 2016 | 52,000.00 |
| Sep 30, 2016 | 52,000.00 |
| Jun 30, 2016 | 124,000.00 |
| Jun 30, 2016 | 124,000.00 |
| Mar 31, 2016 | 719,000.00 |
| Mar 31, 2016 | 719,000.00 |
| Dec 31, 2015 | 187,000.00 |
| Dec 31, 2015 | 187,000.00 |
| Sep 30, 2015 | 29.10 Mn |
| Sep 30, 2015 | 29.10 Mn |
| Jun 30, 2015 | 29.25 Mn |
| Jun 30, 2015 | 29.25 Mn |
| Mar 31, 2015 | 28.79 Mn |
| Mar 31, 2015 | 28.79 Mn |
| Dec 31, 2014 | 28.65 Mn |
| Dec 31, 2014 | 28.65 Mn |
| Sep 30, 2014 | 28.34 Mn |
| Sep 30, 2014 | 28.34 Mn |